Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 12/2018

Ausgabe 12/2018

Inhaltsverzeichnis ( 15 Artikel )

22.08.2018 | Original Article | Ausgabe 12/2018

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma

Chao Yang, He Cheng, Yiyin Zhang, Kun Fan, Guopei Luo, Zhiyao Fan, Qiuyi Huang, Yu Lu, Kaizhou Jin, Zhengshi Wang, Xianjun Yu, Chen Liu

31.08.2018 | Original Article | Ausgabe 12/2018

Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)

Sabine Schmid, Stefan Diem, Qiyu Li, Mirjam Krapf, Lukas Flatz, Sebastian Leschka, Lotus Desbiolles, Dirk Klingbiel, Wolfram Jochum, Martin Früh

06.09.2018 | Original Article | Ausgabe 12/2018

Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies

Allison S. Dobry, Cheryl K. Zogg, F. Stephen Hodi, Timothy R. Smith, Patrick A. Ott, J. Bryan Iorgulescu

14.09.2018 | Original Article | Ausgabe 12/2018

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy

Henning Zelba, Jonas Bochem, Graham Pawelec, Claus Garbe, Kilian Wistuba-Hamprecht, Benjamin Weide

12.09.2018 | Clinical Trial Report | Ausgabe 12/2018 Open Access

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma

Jhanelle E. Gray, Alberto Chiappori, Charlie C. Williams, Tawee Tanvetyanon, Eric B. Haura, Ben C. Creelan, Jongphil Kim, Theresa A. Boyle, Mary Pinder-Schenck, Farah Khalil, Soner Altiok, Rebecca Devane, David Noyes, Melanie Mediavilla-Varela, Renee Smilee, Emily L. Hopewell, Linda Kelley, Scott J. Antonia

15.11.2017 | Focussed Research Review | Ausgabe 12/2018

Cancer vaccine strategies: translation from mice to human clinical trials

Jay A. Berzofsky, Masaki Terabe, Jane B. Trepel, Ira Pastan, David F. Stroncek, John C. Morris, Lauren V. Wood

20.12.2017 | Focussed Research Review | Ausgabe 12/2018

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints

Avishai Shemesh, Michael Brusilovsky, Kiran Kundu, Aner Ottolenghi, Kerry S. Campbell, Angel Porgador

22.02.2018 | Focussed Research Review | Ausgabe 12/2018

Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?

S. M. Mansour Haeryfar, Christopher R. Shaler, Patrick T. Rudak

29.03.2018 | Focussed Research Review | Ausgabe 12/2018 Open Access

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

Daniel Rojas-Sepúlveda, Andrés Tittarelli, María Alejandra Gleisner, Ignacio Ávalos, Cristián Pereda, Iván Gallegos, Fermín Eduardo González, Mercedes Natalia López, Jean Michel Butte, Juan Carlos Roa, Paula Fluxá, Flavio Salazar-Onfray

11.04.2018 | Focussed Research Review | Ausgabe 12/2018

Personalized cancer vaccines: adjuvants are important, too

Cécile Gouttefangeas, Hans-Georg Rammensee

10.05.2018 | Focussed Research Review | Ausgabe 12/2018

Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment

Katerina Pilatova, Beatrix Bencsikova, Regina Demlova, Dalibor Valik, Lenka Zdrazilova-Dubska

10.05.2018 | Focussed Research Review | Ausgabe 12/2018

Cystatin F as a regulator of immune cell cytotoxicity

Janko Kos, Milica Perišić Nanut, Mateja Prunk, Jerica Sabotič, Esmeralda Dautović, Anahid Jewett

25.06.2018 | Focussed Research Review | Ausgabe 12/2018

Dendritic cell trafficking in tumor-bearing mice

Sarah C. Krzastek, Ekaterine Goliadze, Shaoqing Zhou, Albert Petrossian, Fatma Youniss, Gobalakrishnan Sundaresan, Li Wang, Jamal Zweit, Georgi Guruli

19.09.2018 | Focussed Research Review | Ausgabe 12/2018

The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer

Nathan Karin, Hila Razon

02.11.2018 | Focussed Research Review | Ausgabe 12/2018

Targeting CTCFL/BORIS for the immunotherapy of cancer

Dmitri Loukinov

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise